StockData
Reviva Pharmaceuticals Holdings, Inc. logo

Reviva Pharmaceuticals Holdings, Inc. (RVPH) stock

RVPHOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 2/30
$0.45−0.02 (-4.36%)

Close on Oct 19, 2026Market cap $5.94MP/E –Yield –

How the market prices Reviva Pharmaceuticals

Each ratio against its own distribution since 2020, from month-end prices and the figures reported at the time

Reviva Pharmaceuticals trades at 0.4× its earnings, against a median of 4.6× since 2020 — cheaper than 96% of the months in between.

The shaded bar covers the 5th to 95th percentile of month-end values since 2020, the darker part the 25th to 75th, the line the median and the dot today. The figure on the right is the percentile today sits at.

Price to book since 2020

Median 4.6×, today 0.4×

What it earns on the capital it uses

Trailing twelve months over average capital

Return on equity-128.3%vs -53.5%
Return on assets-68.8%vs -40.7%
Return on capital employed-90.8%vs -38.7%

How hard the assets work

Profit per employee-$807.89Kvs -$704.12K

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

What it owes and what covers it

Latest balance sheet, against twelve months of cash generation

Cash and short-term investments exceed every borrowing by $17.41M.

Total debt$44.39K
Cash and short-term investments$17.46M
EBITDA, trailing twelve months-$11.88M

Leverage and liquidity

Debt to equity0.00vs 0.50
Current ratio3.39vs 3.30
Quick ratio3.19vs 2.39

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Scores and rules of thumb

Academic scores computed from the latest two fiscal years. They are screens, not verdicts.

Piotroski F-Score

Nine yes-or-no tests of profit, leverage and efficiency against last year.

3 of 9 tests passed

How the shares have traded

Total return includes reinvested dividends, to the close on Oct 19, 2026

Total return against the S&P 500

The axis is compressed: each step is ten times the one before, so a month and a decade fit on the same line.

RVPHS&P 500
PeriodRVPHS&P 500DifferenceRVPH per yearS&P 500 per year
1 month-6.2%+0.6%−6.9 pts
3 months-20.4%+3.4%−23.7 pts
Year to date-91.9%+13.3%−105.2 pts
1 year-96.1%+16.6%−112.7 pts
3 years-99.4%+86.4%−185.8 pts-81.8%+23.1%
5 years-99.3%+81.9%−181.2 pts-63.5%+12.7%

Who is betting against it

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M RVPH shares were sold short on Oct 30, 2026, up 0.8% from the previous report. At recent volumes it would take 6.7 days to buy them back. Over the last 20 sessions, 50.5% of the volume reported to FINRA was short selling.

Shares sold shortDays to cover

The last twelve reports

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 2026403,277+0.8%59,9306.7
Oct 15, 2026400,229-0.4%50,2078.0
Sep 30, 2026401,987-0.8%33,35912.1
Sep 15, 2026405,082+1.2%53,8677.5
Aug 31, 2026400,267-0.0%52,7117.6
Aug 14, 2026400,313-2.1%56,0987.1
Jul 31, 2026408,776-4.2%120,8073.4
Jul 15, 2026426,525-14.0%114,9303.7
Jun 30, 2026496,237-13.8%111,7304.4
Jun 15, 2026575,626-15.4%289,8712.0
May 29, 2026680,054-44.2%433,3671.6
May 15, 20261,217,792-34.7%1,655,7721.0

Every measure, in full

30 figures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Sep 30, 2026
Share price as of
–

Share statisticsIndustry

Shares Change (YoY)
271.8%
10.9%
Shares Change (QoQ)
0.00%
0.57%
Shares Held by Institutions
0.06%
56.2%

Returns on capitalIndustry

Return on Equity (ROE)
-128.3%
-53.5%
Return on Assets (ROA)
-68.8%
-40.7%
Return on Capital Employed (ROCE)
-90.8%
-38.7%

Financial positionIndustry

Current Ratio
3.39
3.30
Quick Ratio
3.19
2.39
Debt / Equity
0.00
0.50
Interest Coverage
-2310.59
-6.20

EfficiencyIndustry

Profits Per Employee
-$807.89K
-$704.12K
Employee Count
14
75

Income statement (TTM)Industry

Operating Income
-$11.88M
-$21.49M
Pretax Income
-$11.30M
-$14.83M
Net Income
-$11.31M
-$22.47M
EBITDA
-$11.88M
-$17.14M
EPS (Diluted)
-$1.40
-$0.83

Balance sheetIndustry

Total Debt
$44.39K
$116.91M
Net Cash (Debt)
$17.41M
$15.35M
Net Cash Per Share
$1.33
$0.71
Equity (Book Value)
$13.08M
$49.84M
Book Value Per Share
$1.00
$1.45
Tangible Book Value
$13.08M
$23.91M
Working Capital
$13.08M
$74.41M

Cash flow (TTM)Industry

Operating Cash Flow
-$13.90M
-$12.17M

Taxes and interestIndustry

Interest Expense
$5.14K
$3.07M
Income Tax
$10.79K
$80.43K

Scores and fair valueIndustry

Piotroski F-Score
3
4

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?